KRT19 and colorectal carcinoma: Particularly CEA [37], [38], also in combination with markers such as CK19, CK20, hTERT, TIMP-1, miR141 [39]–[41], is recognized as potential aid in early detection of CRC, as prognostic marker for recurrence, and also as predictive biomarker with respect to therapy response.